Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$572M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$495M |
| 3 |
iShares MBS ETF
MBB
|
+$405M |
| 4 |
Procter & Gamble
PG
|
+$365M |
| 5 |
Microsoft
MSFT
|
+$327M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$605M |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$544M |
| 3 |
Sempra
SRE
|
+$474M |
| 4 |
CELG
Celgene Corp
CELG
|
+$411M |
| 5 |
BPL
Buckeye Partners, L.P.
BPL
|
+$380M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 8.85% |
| 2 | Healthcare | 5.77% |
| 3 | Financials | 5.26% |
| 4 | Consumer Discretionary | 4.71% |
| 5 | Communication Services | 4.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CLCT
4901
DELISTED
Collectors Universe
CLCT
| $215K | ﹤0.01% |
9,328
+5,334
| +134% | +$143K |
|
4902
CALL
Infosys
INFY
$48.7B
| $214K | ﹤0.01% |
20,700
+19,700
| +1,970% | +$198K |
|
4903
Solid Biosciences
SLDB
$794M
| $214K | ﹤0.01% |
3,208
+2,556
| +392% | +$282K |
|
4904
Graham Corp
GHM
$1.12B
| $213K | ﹤0.01% |
9,753
+4,822
| +98% | +$104K |
|
4905
CALL
Webster Financial
WBS
$12.5B
| $213K | ﹤0.01% |
4,000
+1,800
| +82% | +$86.6K |
|
|
ENDP
4906
CALL
DELISTED
Endo International plc
ENDP
| $213K | ﹤0.01% |
45,500
-520,500
| -92% | -$2.32M |
|
|
IHC
4907
DELISTED
Independence Holding Company
IHC
| $213K | ﹤0.01% |
5,066
+2,547
| +101% | +$102K |
|
4908
IES Holdings
IESC
$14.8B
| $212K | ﹤0.01% |
8,255
+4,156
| +101% | +$89.9K |
|
|
MRSH
4909
PUT
Marsh
MRSH
$90.5B
| $212K | ﹤0.01% |
1,900
-6,600
| -78% | -$689K |
|
4910
PUT
Southern Copper
SCCO
$143B
| $212K | ﹤0.01% |
5,394
-11,758
| -69% | -$409K |
|
|
UBX
4911
DELISTED
Unity Biotechnology
UBX
| $212K | ﹤0.01% |
2,935
+1,538
| +110% | +$109K |
|
|
BFIN
4912
DELISTED
BankFinancial
BFIN
| $211K | ﹤0.01% |
16,176
+7,011
| +76% | +$91.2K |
|
|
VWTR
4913
DELISTED
Vidler Water Resouces, Inc. Common Stock
VWTR
| $211K | ﹤0.01% |
19,000
+9,681
| +104% | +$103K |
|
4914
PUT
Principal Financial Group
PFG
$24.3B
| $209K | ﹤0.01% |
3,800
+2,400
| +171% | +$131K |
|
|
FPRX
4915
DELISTED
Five Prime Therapeutics, Inc.
FPRX
| $209K | ﹤0.01% |
45,533
+14,287
| +46% | +$56.6K |
|
|
TLRD
4916
CALL
DELISTED
Tailored Brands, Inc.
TLRD
| $208K | ﹤0.01% |
50,200
-50,400
| -50% | -$237K |
|
|
SBBX
4917
DELISTED
SB One Bancorp Common Stock
SBBX
| $208K | ﹤0.01% |
8,340
+4,188
| +101% | +$96.8K |
|
|
EGLE
4918
DELISTED
Eagle Bulk Shipping Inc.
EGLE
| $208K | ﹤0.01% |
6,446
+2,877
| +81% | +$88.5K |
|
4919
CALL
Aecom
ACM
$9.3B
| $207K | ﹤0.01% |
4,800
-29,600
| -86% | -$1.23M |
|
4920
KLX Energy Services
KLXE
$45M
| $207K | ﹤0.01% |
6,422
+1,775
| +38% | +$66K |
|
4921
Culp Inc
CULP
$44.1M
| $206K | ﹤0.01% |
15,138
+1,325
| +10% | +$20.3K |
|
|
SA
4922
CALL
Seabridge Gold
SA
$2.78B
| $206K | ﹤0.01% |
14,900
+2,000
| +16% | +$25.3K |
|
4923
PUT
Teradyne
TER
$57.6B
| $205K | ﹤0.01% |
3,000
-3,200
| -52% | -$203K |
|
4924
USA Compression Partners
USAC
$3.79B
| $205K | ﹤0.01% |
11,274
+4,387
| +64% | +$74.8K |
|
4925
Verrica Pharmaceuticals
VRCA
$89.7M
| $205K | ﹤0.01% |
1,290
+654
| +103% | +$96.5K |
|
Similar funds
Barclays's Q4 2019 Portfolio in Review
As of Q4 2019, Barclays held 7,254 positions worth $180B, up 13% from $160B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Barclays deployed $6.1B of net new capital in Q4 2019, opening 260 new positions and adding to 3,541 existing holdings. Its largest new stake was Pacer iPath Gold ETNs: 1,000,000 shares worth $25.3M.
By sector, the portfolio is most concentrated in Technology at 8.9% of assets, up from 7.7% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Invesco QQQ Trust, an estimated $605M trimmed.
- Barclays's largest Q4 2019 buy was Pacer iPath Gold ETNs: 1,000,000 shares worth $25.3M.
- Barclays added most to Apple in Q4 2019, an estimated $572M increase.
- Barclays's biggest Q4 2019 reduction was Invesco QQQ Trust, cutting an estimated $605M.
- Barclays fully exited Celgene Corp in Q4 2019, selling an estimated $411M.
- Barclays's ten largest holdings make up 26% of its $180B portfolio in Q4 2019.
- Barclays opened 260 new positions and closed 700 in Q4 2019.
- Barclays's portfolio value rose 13% quarter-over-quarter to $180B.
Based on Barclays's 13F filing for Q4 2019, filed 10 Feb 2020.